Jeune Aesthetics, a wholly owned subsidiary of Krystal Biotech (KRYS), announced the appointment of Nishant Saxena as Chief Financial Officer, CFO, effective January 15, 2025. Most recently, Saxena was a Managing Director in Evercore’s (EVR) healthcare group.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRYS:
- Krystal Biotech early lung cancer data ‘promising,’ says H.C. Wainwright
- Krystal Biotech Reports Positive Results for KYANITE-1 Study
- Krystal Biotech announces initial clinical results from KYANITE-1 study
- Krystal Biotech Reports Promising Results for Genetic Medicine
- Krystal Biotech announces initial update for KB408, KB407